Nanoform Biologics’ high-dose subcutaneous delivery platform represents a significant advancement in the field of biologics. By addressing the challenges associated with subcutaneous delivery, such as volume limitations and protein aggregation, Nanoform’s technology enables the development of highly concentrated, stable, and subcutaneously injectable biologic formulations.